Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2013 Jan 15;127(2):180-7.
doi: 10.1161/CIRCULATIONAHA.111.077487. Epub 2012 Dec 4.

The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study

Affiliations
Randomized Controlled Trial

The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study

Jonathan Q Purnell et al. Circulation. .

Abstract

Background: Intensive diabetes mellitus therapy of type 1 diabetes mellitus reduces diabetes mellitus complications but can be associated with excess weight gain, central obesity, and dyslipidemia. The purpose of this study was to determine whether excessive weight gain with diabetes mellitus therapy of type 1 diabetes mellitus is prospectively associated with atherosclerotic disease.

Methods and results: Subjects with type 1 diabetes mellitus (97% white, 45% female, mean age 35 years) randomly assigned to intensive or conventional diabetes mellitus treatment during the Diabetes Control and Complications Trial (DCCT) underwent intima-media thickness (n = 1015) and coronary artery calcium score (n = 925) measurements during follow-up in the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Intensive treatment subjects were classified by quartile of body mass index change during the DCCT. Excess gainers (4th quartile, including conventional treatment subjects meeting this threshold) maintained greater body mass index and waist circumference, needed more insulin, had greater intima-media thickness (+5%, P < 0.001 EDIC year 1, P = 0.003 EDIC year 6), and trended toward greater coronary artery calcium scores (odds ratio, 1.55; confidence interval, 0.97 to 2.49; P = 0.07) than minimal gainers. DCCT subjects meeting metabolic syndrome criteria for waist circumference and blood pressure had greater intima-media thickness in both EDIC years (P = 0.02 to < 0.001); those meeting high-density lipoprotein criteria had greater coronary artery calcium scores (odds ratio, 1.6; confidence interval, 1.1 to 2.4; P = 0.01) during follow-up. Increasing frequency of a family history of diabetes mellitus, hypertension, and hyperlipidemia was associated with greater intima-media thickness with intensive but not conventional treatment.

Conclusions: Excess weight gain in DCCT is associated with sustained increases in central obesity, insulin resistance, dyslipidemia and blood pressure, as well as more extensive atherosclerosis during EDIC.

Clinical trial registration: URL for DCCT: http://clinicaltrials.gov; Unique identifier: NCT00360815. URL for EDIC: http://clinicaltrials.gov; Unique identifier: NCT00360893.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Body mass index (left graph) and waist circumference (right graph) of subjects treated intensively in the DCCT/EDIC cohort during the DCCT and study years 1 and 6 of EDIC. P < 0.001 for both BMI and waist circumference comparing the fourth quartile of weight gain during the DCCT (Q4, excess gainers) (n=122) vs. quartiles Q1-3 (n=394, minimal-gainers, shown in graphs separately) at each study time point by Mann-Whitney Rank Sum Test. Waist circumference not measured at DCCT baseline. Results are mean ± SE.
Figure 2
Figure 2
Intima media thickness (IMT) of the common carotid of conventionally (n=499) and intensively in the DCCT subjects, measured at EDIC study years 1 and 6. *P<0.001 vs. minimal gainers with intensive therapy (n=394) in years 1 and 6. †P<0.001 vs. excess gainers with intensive therapy (n=122) EDIC year 1. ‡P=0.003 and §P=0.03 vs. excess gainers in year 1 and 6, respectively. Analysis by Mann-Whitney Rank Sum Test (for fully adjusted significance values see Tables 2 and 3). Box plots show 5th, 10th, 25th, median, 75th, 90th, and 95th percentiles lines, bottom to top.
Figure 3
Figure 3
Distribution of coronary artery calcification (CAC) scores of subjects treated intensively in the DCCT/EDIC cohort, excess gainers versus minimal gainers during DCCT. See table 4 for significance.

Comment in

Similar articles

Cited by

References

    1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The diabetes control and complications trial research group. N Engl J Med. 1993;329:977–986. - PubMed
    1. Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trial. Am J Cardiol. 1995;75:894–903. - PubMed
    1. Cleary PA, Orchard TJ, Genuth S, Wong ND, Detrano R, Backlund JY, Zinman B, Jacobson A, Sun W, Lachin JM, Nathan DM. The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the diabetes control and complications trial/epidemiology of diabetes interventions and complications (dcct/edic) study. Diabetes. 2006;55:3556–3565. - PMC - PubMed
    1. Nathan DM, Lachin J, Cleary P, Orchard T, Brillon DJ, Backlund JY, O’Leary DH, Genuth S. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med. 2003;348:2294–2303. - PMC - PubMed
    1. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643–2653. - PMC - PubMed

Publication types

MeSH terms

Associated data